PBBIF Stock - Probi AB (publ)
Unlock GoAI Insights for PBBIF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $61.95M | $59.05M | $72.47M | $87.33M | $66.89M |
| Gross Profit | $21.84M | $24.39M | $31.71M | $37.74M | $31.16M |
| Gross Margin | 35.2% | 41.3% | 43.8% | 43.2% | 46.6% |
| Operating Income | $1.11M | $4.80M | $11.84M | $15.01M | $11.68M |
| Net Income | $1.66M | $3.88M | $9.15M | $11.29M | $9.17M |
| Net Margin | 2.7% | 6.6% | 12.6% | 12.9% | 13.7% |
| EPS | $0.15 | $0.34 | $0.80 | $0.99 | $0.81 |
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.
Visit WebsiteEarnings History & Surprises
PBBIFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Oct 22, 2024 | — | $0.03 | — | — |
Q3 2024 | Jul 16, 2024 | — | $0.07 | — | — |
Q2 2024 | Apr 23, 2024 | — | $0.02 | — | — |
Q1 2024 | Jan 26, 2024 | — | $-0.02 | — | — |
Q3 2023 | Sep 29, 2023 | — | $0.05 | — | — |
Q2 2023 | Jun 29, 2023 | — | $-0.05 | — | — |
Q1 2023 | Mar 30, 2023 | — | $0.16 | — | — |
Q1 2023 | Jan 27, 2023 | $1.89 | $-0.50 | -126.5% | ✗ MISS |
Q4 2022 | Oct 21, 2022 | $2.13 | $1.09 | -48.8% | ✗ MISS |
Q3 2022 | Jul 15, 2022 | $1.58 | $1.75 | +10.8% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $2.31 | $1.23 | -46.8% | ✗ MISS |
Q1 2022 | Feb 2, 2022 | $2.29 | $2.31 | +0.9% | ✓ BEAT |
Q4 2021 | Oct 22, 2021 | $2.23 | $1.62 | -27.4% | ✗ MISS |
Q3 2021 | Jul 16, 2021 | $2.43 | $1.39 | -42.8% | ✗ MISS |
Q2 2021 | Apr 23, 2021 | $2.04 | $1.99 | -2.5% | ✗ MISS |
Q1 2021 | Feb 9, 2021 | $2.43 | $1.92 | -21.0% | ✗ MISS |
Q4 2020 | Oct 21, 2020 | $2.12 | $2.91 | +37.3% | ✓ BEAT |
Q3 2020 | Jul 17, 2020 | $1.51 | $2.37 | +57.0% | ✓ BEAT |
Q2 2020 | Apr 24, 2020 | $1.78 | $0.94 | -47.2% | ✗ MISS |
Q1 2020 | Feb 11, 2020 | $1.52 | $2.27 | +49.3% | ✓ BEAT |
Latest News
Frequently Asked Questions about PBBIF
What is PBBIF's current stock price?
What is the analyst price target for PBBIF?
What sector is Probi AB (publ) in?
What is PBBIF's market cap?
Does PBBIF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PBBIF for comparison